| __timestamp | Halozyme Therapeutics, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 22732000 | 570979 |
| Thursday, January 1, 2015 | 29245000 | 2185000 |
| Friday, January 1, 2016 | 33206000 | 4554000 |
| Sunday, January 1, 2017 | 31152000 | 3605000 |
| Monday, January 1, 2018 | 10136000 | 5527000 |
| Tuesday, January 1, 2019 | 45546000 | 5234000 |
| Wednesday, January 1, 2020 | 43367000 | 6126000 |
| Friday, January 1, 2021 | 81413000 | 6784000 |
| Saturday, January 1, 2022 | 139304000 | 7592000 |
| Sunday, January 1, 2023 | 192361000 | 11450000 |
| Monday, January 1, 2024 | 159417000 |
Cracking the code
In the dynamic world of biotechnology, understanding cost structures is crucial. Over the past decade, Halozyme Therapeutics, Inc. and Travere Therapeutics, Inc. have shown distinct trajectories in their cost of revenue. Halozyme's cost of revenue surged by over 740% from 2014 to 2023, reflecting its aggressive growth and expansion strategies. In contrast, Travere's costs increased by approximately 1,900%, albeit from a much smaller base, indicating a more conservative yet steady growth path.
These trends highlight the differing strategies and market positions of these two biotech firms, offering valuable insights for investors and industry analysts.
Novo Nordisk A/S vs Halozyme Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Novo Nordisk A/S and Travere Therapeutics, Inc.
Cost of Revenue Trends: Vertex Pharmaceuticals Incorporated vs Halozyme Therapeutics, Inc.
Analyzing Cost of Revenue: Neurocrine Biosciences, Inc. and Travere Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Bio-Techne Corporation vs Halozyme Therapeutics, Inc.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Halozyme Therapeutics, Inc.'s Expenses
Analyzing Cost of Revenue: Halozyme Therapeutics, Inc. and Pharming Group N.V.
Cost of Revenue Comparison: Halozyme Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Halozyme Therapeutics, Inc. and Mesoblast Limited's Expenses
Halozyme Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored
Comparing Cost of Revenue Efficiency: Halozyme Therapeutics, Inc. vs MiMedx Group, Inc.
ACADIA Pharmaceuticals Inc. vs Travere Therapeutics, Inc.: Efficiency in Cost of Revenue Explored